Akili Grabs CE Mark for Children’s Digital ADHD Treatment Post author:Sam Post published:June 22, 2020 Post category:Devices & Diagnostics Letter The FDA last week cleared EndeavorRx for marketing in the U.S. Source: Devices & Diagnostics Letter You Might Also Like Gilead’s Remdesivir Gains Orphan Drug Status as Possible COVID-19 Treatment March 24, 2020 Sinopharm to Begin Phase 3 Trial of its COVID-19 Vaccine Candidate in Peru August 20, 2020 Large Hydroxychloroquine Study Gets Under Way May 21, 2020
